Reviews/Caffeine and Performance/Caffeine improves strength and power
Strength Power · CAFF-PWR-01 · v2
Twelve randomised controlled trials in this corpus tested whether taking caffeine before exercise improves muscular strength and power, and most found that it does. The benefit shows up most clearly in lower-body, heavier lifts such as the back squat, and less so in upper-body movements like the bench press. Two well-run trials found no benefit at all, one in athletes already used to caffeine and one in collegiate athletes at a lower dose. Several of the strongest positive trials come from the same research group using very similar methods, and one trial found the effect did not reliably repeat from day to day. The panel judged the effect to be real but conditional on dose, load, muscle group and habituation, rather than a universal boost, which is why it sits short of the top tier.
The on-claim evidence is twelve RCTs, and the majority report significant caffeine-driven gains in strength and power ([1],[2],[4],[8],[11],[12]), concentrated at moderate-to-high loads and in lower-body work; [1] (N=94, 3 mg/kg) found caffeine significantly improved strength across conditions (p < 0.01), and [11] found 8 mg/kg significantly improved bench press, squat and deadlift strength (p < 0.001). Lower-body benefits also appear in [3] (back squat +2.8%) and [10] (back squat at 75-100% 1RM). The benefit is load- and muscle-group dependent: [2], [3] and [10] found no bench-press improvement. Two trials are null ([6] in habituated athletes at 9 and 11 mg/kg; [9] in collegiate athletes at 3 mg/kg), and [5] reports 'limited effects' with only a small countermovement-jump effect. The contested point: The division is whether the unqualified word 'improves' is warranted: the positive majority supports a real effect, but [6] and [9] are genuine nulls and upper-body strength is repeatedly unaffected ([2],[3],[10]). The effect is also contingent on dose and habituation ([6],[11]) and its reproducibility is questioned by [7], which found the ergogenic effect may not be repeatable between days.
All 13 papers behind this claim with their DOIs and what each does to it, the panel’s arbitration, the evidence gap map and the open research questions. Free, and sent to your inbox.
We’ll also send you other claims from Caffeine and Performance, one at a time, and tell you when a release or a pivotal trial changes a grade. Unsubscribe by replying.
One reviewer's only job is to attack the finding. The challenges below were weighed before the grade was set.
Four of the strongest positive RCTs ([1],[4],[8],[10]) share the Montalvo-Alonso / del Val-Manzano lab with near-identical protocols, so apparent corpus consistency partly reflects one research programme rather than independent replication.
Two well-conducted RCTs report no effect: [6] (habituated athletes, 9-11 mg/kg) and [9] (collegiate athletes, 3 mg/kg). The unconditional wording 'improves' overreaches these nulls.
Where it remains uncertain. Two well-conducted trials are null ([6] habituated, 9-11 mg/kg; [9] collegiate, 3 mg/kg), upper-body strength is often unaffected ([2],[3],[10]), and [7] found the effect may not be repeatable between days.
Aleatory
Most trials have small samples (N=13-29), so individual estimates are noisy and effect sizes may be inflated.
Epistemic
Four strong positive trials ([1],[4],[8],[10]) share one lab and near-identical protocols, so independent replication is limited.
The load-bearing papers from a corpus of 13, each classified by what it does to the claim. Every DOI is taken from the corpus the claim was graded on.
Largest RCT (N=94); direct positive evidence for strength.
“Acute ingestion of 3 mg/kg caffeine enhances strength and endurance performance in resistance-trained men and women.”
Panel auditInternal validity: high · scope of inference: Acute 3 mg/kg caffeine on bench press and back squat velocity in resistance-trained men and women.Key limitations: acute single-dose design · velocity as strength proxy, not 1RM · effect varies by CYP1A2 genotype
Positive, but establishes load- and muscle-group-dependence of the effect.
“Acute caffeine intake (3 mg/kg) improved muscular strength, power and endurance performance, revealing a more pronounced effect at high-loads (≥ 75% 1RM) and in lower-body (back squat) than in upper-body exercise (bench press) according to muscle group size.”
Panel auditInternal validity: high · scope of inference: Acute 3 mg/kg caffeine on upper- and lower-body strength/power in resistance-trained athletes; effect concentrated in lower-body at high loads.Key limitations: small sample · no effect in bench press (upper body) · acute single-dose design
Highly cited positive trial showing partial/selective effect on strength and power.
“The results point to an acute benefit of caffeine intake in enhancing lower-body strength, likely due to a decrease in RPE; upper-, but not lower-body power; and no effects on muscular endurance, in resistance-trained men.”
Panel auditInternal validity: high · scope of inference: Acute 6 mg/kg caffeine on lower-body strength and upper-body power in resistance-trained men; benefit not uniform across all tests.Key limitations: small sample · no benefit on bench press 1RM · upper- but not lower-body power improved
Contradicting null; bounds the claim to non-habituated/moderate-dose conditions.
“The results of the present study indicate that high acute doses of CAF (9 and 11 mg/kg/b.m.) did not improve muscle strength nor muscle endurance in athletes habituated to this substance.”
Panel auditInternal validity: high · scope of inference: High-dose acute caffeine (9-11 mg/kg) on bench press strength/power in caffeine-habituated male athletes; no benefit, reduced peak velocity.Key limitations: small sample · only habituated high consumers · high doses atypical of ergogenic recommendations · single exercise (bench press)
4 of 13 papers shown. The full review lists all of them, with the panel’s arbitration →
Claims are graded at each quarterly release, and re-graded between releases only when a pivotal trial lands. Every change is a new version of the claim.
A consistent positive RCT majority with sound blinded designs supports the claim, but genuine nulls, muscle-group specificity, author-cluster overlap, and a reproducibility caveat hold it below the Established band.
Release 2026-q4 re-graded every claim from its corpus under protocol v0.19. An earlier release's grade is shown for the record; it came from an earlier protocol and is not a movement.
Assumptions that carry weight but are not themselves established.
The panel records the gap that would most move the claim, and the study that would close it.
Independent multi-lab replication. Much of the positive signal shares one lab and protocol ([1],[4],[8],[10]), so corpus consistency may overstate robustness. The panel rates this the highest-importance open gap for the claim, and names the study design that would close it: A pre-registered, adequately powered RCT run by labs unconnected to the Montalvo-Alonso / del Val-Manzano programme using a standardised strength/power protocol.
Open question: Does acute caffeine improve upper-body maximal strength, or is the benefit confined to lower-body and high-load work? Why it is still open: [2], [3] and [10] find no bench-press strength improvement while back-squat strength improves.
Priors is a sceptical first reader, not peer review, and not medical advice.
Release 2026-q4 · graded 21 Oct 2026 · protocol v0.19